Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Characterization of the Neo-squamous Epithelial Barrier

NCT03077594
completednot_applicable

Influence of Central Obesity on the Esophageal Epithelial Barrier

NCT02776982
withdrawnnot_applicable

HRIM vs Mucosal Impedance in GERD Participants

NCT02812407
completednot_applicable

Mucosal Impedance and Eosinophilic Esophagitis

NCT01953575

Clinical Trials (4)

Showing 4 of 4 trials
NCT03077594

Characterization of the Neo-squamous Epithelial Barrier

Completed
NCT02776982Not Applicable

Influence of Central Obesity on the Esophageal Epithelial Barrier

Completed
NCT02812407Not Applicable

HRIM vs Mucosal Impedance in GERD Participants

Withdrawn
NCT01953575Not Applicable

Mucosal Impedance and Eosinophilic Esophagitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4